Homework Help: human risk assessment

Posted by Thano on Monday, October 29, 2007 at 1:31am.

Equal concentrations of heptachlor, a known human carcinogen, are found at two different sites.
(a) The incremental risk is the same at the two sites
(b) The incremental risk is different at the two sites
(c) The incremental risk at the two sites might be the same or it might be different.

human risk assessment - drwls, Monday, October 29, 2007 at 1:54am
Your question is incomplete
human risk assessment - bobpursley, Monday, October 29, 2007 at 8:36am
Risk analysis for this long lasting compound will depend on the usage of the soil. Is there farming or gardening, or children playing on it? Is it used for parking?
human risk assessment - Dr Russ, Monday, October 29, 2007 at 10:05am
Depending on the detail required for your question you may also want to look at human take up/elimination rates.
- human risk assessment - Danielle, Monday, October 29, 2007 at 11:12am
  Dr Russ is totally right- you should take more advice from him
  
  Dr Russ- if you read this message plz tell me if ur the Dr Russ from neasham road surgury!!

Answer this Question

Related Questions

human risk assessment - The dose for an incremental lifetime cancer risk of 10-6...
human risk assessment - What is meant by inhalation reference concentration (RfC...
MGT 437 - Which one of the following is not a project risk? a)Political Risk b) ...
sci 275 - create a outline of the risk of using malathion according to the four ...
science - Create an outline of the risk of using Malathion according to the four...
science - presents you revaluation of the risk malathion assessment. consider ...
Science 275 - Create an outline of the risk of using Malathion according to the ...
human risk assessment - What are the advantages and disadvantages of animal ...
human risk assessment - 225ug/L*.86ug/m3*13.1m3/day*1033ug/m3*10years/52kg
human risk assessment - What are the advantages and disadvantages of animal ...

For Further Reading

First Name:
School Subject:
Answer: